Cerity Partners
MXCT icon

Cerity Partners’s MaxCyte MXCT Stock Holding History

Cerity Partners’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.1K Buy
+45,662
New +$42.6K ﹤0.01% 3147
2025
Q4 		– Sell
-30,672
Closed -$48.5K – 2973
2025
Q3 		$48.5K Buy
+30,672
New +$53.3K ﹤0.01% 2700
2023
Q3 		– Sell
-12,510
Closed -$57.7K – 1605
2023
Q2 		$57.7K Buy
+12,510
New +$57.5K ﹤0.01% 1566

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Cerity Partners's MXCT Position: Q1 2026 in Review

Cerity Partners opened a new position in MaxCyte (MXCT) in Q1 2026: 45,662 shares worth $32.1K. The stake represents ﹤0.01% of the portfolio and ranks #3147 among its holdings. This is a return to the name: Cerity Partners previously reported a position in MXCT as recently as Q3 2025.

Cerity Partners first reported a position in MXCT in Q2 2023 and has held it in 3 quarters since. The position peaked at $57.7K in Q2 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Cerity Partners held 45,662 shares of MaxCyte worth $32.1K as of Q1 2026.
  • MaxCyte was a new Cerity Partners position in Q1 2026.
  • MaxCyte made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #3147 holding.
  • Cerity Partners first reported a position in MaxCyte in Q2 2023 and has held it in 3 quarters since.
  • Cerity Partners's MaxCyte position peaked at $57.7K in Q2 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.